These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 20160359)
1. Survey of patient dosimetry for head and neck cancer patients undergoing external radiotherapy treatment: a study from northeastern hospitals of India. Sharma AB; Singh TT; Singh KN; Gartia RK J Cancer Res Ther; 2009; 5(4):263-6. PubMed ID: 20160359 [TBL] [Abstract][Full Text] [Related]
2. In vivo dosimetry for external photon treatments of head and neck cancers by diodes and TLDS. Tung CJ; Wang HC; Lo SH; Wu JM; Wang CJ Radiat Prot Dosimetry; 2004; 111(1):45-50. PubMed ID: 15367767 [TBL] [Abstract][Full Text] [Related]
3. Concomitant boost radiotherapy compared with conventional radiotherapy in squamous cell carcinoma of the head and neck--a phase III trial from a single institution in India. Ghoshal S; Goda JS; Mallick I; Kehwar TS; Sharma SC Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):212-20. PubMed ID: 18343310 [TBL] [Abstract][Full Text] [Related]
4. Lens dose in MLC-based IMRT treatments of the head and neck. Pawlicki T; Luxton G; Le QT; Findley D; Ma CM Int J Radiat Oncol Biol Phys; 2004 May; 59(1):293-9. PubMed ID: 15093926 [TBL] [Abstract][Full Text] [Related]
5. [Quality control of dosing delivered by in vivo measurements for head and neck radiotherapy]. Farhat L; Besbes M; Bridier A; Kaffel F; Daoud J Cancer Radiother; 2010 Jan; 14(1):69-73. PubMed ID: 19695937 [TBL] [Abstract][Full Text] [Related]
7. Three-dimensional conformal radiotherapy for locally advanced (Stage II and worse) head-and-neck cancer: dosimetric and clinical evaluation. Portaluri M; Fucilli FI; Castagna R; Bambace S; Pili G; Tramacere F; Russo D; Francavilla MC Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1036-43. PubMed ID: 16750321 [TBL] [Abstract][Full Text] [Related]
8. Target localization and treatment verification for intensity modulated conformal radiation therapy of the head and neck region. The AZ-VUB experience. Akademisch Ziekenhuis-Vrije Universiteit Brussel. Verellen D; Linthout N; Storme G Strahlenther Onkol; 1998 Oct; 174 Suppl 2():19-27. PubMed ID: 9810333 [TBL] [Abstract][Full Text] [Related]
9. Intensity-modulated radiation therapy dose prescription, recording, and delivery: patterns of variability among institutions and treatment planning systems. Das IJ; Cheng CW; Chopra KL; Mitra RK; Srivastava SP; Glatstein E J Natl Cancer Inst; 2008 Mar; 100(5):300-7. PubMed ID: 18314476 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of surface and superficial dose for head and neck treatments using conventional or intensity-modulated techniques. Higgins PD; Han EY; Yuan JL; Hui S; Lee CK Phys Med Biol; 2007 Feb; 52(4):1135-46. PubMed ID: 17264375 [TBL] [Abstract][Full Text] [Related]
11. High-precision dosimetry for radiotherapy using the optically stimulated luminescence technique and thin Al2O3:C dosimeters. Yukihara EG; Yoshimura EM; Lindstrom TD; Ahmad S; Taylor KK; Mardirossian G Phys Med Biol; 2005 Dec; 50(23):5619-28. PubMed ID: 16306656 [TBL] [Abstract][Full Text] [Related]
12. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer. Parliament MB; Scrimger RA; Anderson SG; Kurien EC; Thompson HK; Field GC; Hanson J Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):663-73. PubMed ID: 14967418 [TBL] [Abstract][Full Text] [Related]
13. Hypothyroidism after radiotherapy for patients with head and neck cancer. Ozawa H; Saitou H; Mizutari K; Takata Y; Ogawa K Am J Otolaryngol; 2007; 28(1):46-9. PubMed ID: 17162132 [TBL] [Abstract][Full Text] [Related]
14. Intensity-modulated radiotherapy: first results with this new technology on neoplasms of the head and neck. Kuppersmith RB; Greco SC; Teh BS; Donovan DT; Grant W; Chiu JK; Cain RB; Butler EB Ear Nose Throat J; 1999 Apr; 78(4):238, 241-6, 248 passim. PubMed ID: 10224699 [TBL] [Abstract][Full Text] [Related]
15. Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer. Bussels B; Maes A; Hermans R; Nuyts S; Weltens C; Van den Bogaert W Radiother Oncol; 2004 Aug; 72(2):119-27. PubMed ID: 15297131 [TBL] [Abstract][Full Text] [Related]
16. How the implementation of an in-vivo dosimetry protocol improved the dose delivery accuracy in head and neck radiotherapy. Malicki J; Litoborski M; Kierzkowski J; Kosicka G Neoplasma; 2004; 51(2):155-8. PubMed ID: 15190426 [TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of the modifications in the quality assurance system in radiotherapy in the example of in-vivo dosimetry. Malicki J; Litoborski M; Bogusz-Czerniewicz M; Swiezewski A Phys Med; 2009 Dec; 25(4):201-6. PubMed ID: 19286407 [TBL] [Abstract][Full Text] [Related]
19. In vivo dosimetry of high-dose-rate brachytherapy: study on 61 head-and-neck cancer patients using radiophotoluminescence glass dosimeter. Nose T; Koizumi M; Yoshida K; Nishiyama K; Sasaki J; Ohnishi T; Peiffert D Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):945-53. PubMed ID: 15708279 [TBL] [Abstract][Full Text] [Related]
20. Radiation-induced volume changes in parotid and submandibular glands in patients with head and neck cancer receiving postoperative radiotherapy: a longitudinal study. Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Kirwan J; Mendenhall WM Laryngoscope; 2009 Oct; 119(10):1966-74. PubMed ID: 19688858 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]